Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure

Area of Science:

• Cardiology
• Rheumatology
• Immunology

Background:

• Rheumatic diseases elevate cardiovascular (CV) mortality risk, particularly from heart failure (HF) and ischemic heart disease.
• Traditional CV risk factors alone do not fully explain the heightened risk in this population.
• Obesity and hyperlipidemia may paradoxically contribute to CV risk in rheumatic disease patients.

Purpose of the Study:

• To explore the role of immune-mediated mechanisms and chronic inflammation in the pathogenesis of CV disease within rheumatic disease populations.
• To understand the atypical clinical presentations of ischemic heart disease and HF in patients with rheumatic diseases.

Main Methods:

• Review of existing literature on cardiovascular disease in rheumatic diseases.
• Analysis of epidemiological data linking rheumatic conditions to cardiovascular outcomes.
• Investigation of immunological markers and inflammatory pathways implicated in CV disease.

Main Results:

• Immune-mediated pathways and chronic inflammation are significant contributors to CV disease development in rheumatic conditions.
• The interplay between rheumatic disease and CV risk factors presents unique pathophysiological characteristics.
• Standard clinical manifestations of ischemic heart disease and HF may be less pronounced or altered in this patient group.

Conclusions:

• Understanding the unique inflammatory and immune-driven mechanisms is crucial for managing cardiovascular risk in rheumatic diseases.
• Further research is needed to elucidate the specific roles of obesity and hyperlipidemia in this context.
• Tailored diagnostic and therapeutic strategies may be required for cardiovascular complications in patients with rheumatic diseases.